keyword
https://read.qxmd.com/read/38655246/national-safety-monitoring-of-vaccines-from-the-canadian-adverse-events-following-immunization-surveillance-system-caefiss-2018-2019
#41
JOURNAL ARTICLE
Maryem El Jaouhari, Karin Johnson, Helen Anyoti, Yuhui Xu, Charlotte Wells, Ashley Weeks, Allison Yeung, Amanda Shaw, Susanna Ogunnaike-Cooke
BACKGROUND: The Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) is a comprehensive vaccine safety surveillance system that includes both passive and active surveillance of vaccines administered in Canada. This work presents a summary of adverse events following immunization (AEFI) nationally for 2018 and 2019. METHODS: Data extracted from CAEFISS included all AEFI reports received by the Public Health Agency of Canada by April 30, 2022, for vaccines marketed in Canada and administered between January 1, 2018, and December 31, 2019...
January 1, 2024: Canada Communicable Disease Report
https://read.qxmd.com/read/38655243/canadian-vaccine-safety-surveillance-reports-following-immunization-with-seasonal-influenza-vaccines-2021-2022
#42
JOURNAL ARTICLE
Elissa Giang, Yuhui Xu, Thivya Naganathan, Natalia Abraham, Marie-Thérèse Bawolak, Battouli Said Salim, Ashley Weeks, Amanda Shaw, Susanna Ogunnaike-Cooke
BACKGROUND: Seasonal influenza vaccines (SIV) authorized for use in Canada have all undergone rigorous regulatory assessments for safety and effectiveness. Serious adverse events following immunization (AEFI) can occur, though they are rare. Continuous safety surveillance of vaccines during the post-marketing phase is a critical component of vaccination programs. This enables the detection of rare, late onset, or unexpected adverse events. An updated safety summary following the introduction of any new vaccines and/or formulations to immunization programs is necessary for refining the risk-benefit profile of a specific vaccine and maintaining public confidence...
January 1, 2024: Canada Communicable Disease Report
https://read.qxmd.com/read/38653845/epidemiology-pathogenesis-immune-evasion-mechanism-and-vaccine-development-of-porcine-deltacoronavirus
#43
REVIEW
Xueting Shan, Rui Li, Xiang Ma, Guoqiang Qiu, Yi Xiang, Xiaojun Zhang, De Wu, Lu Wang, Jianhong Zhang, Tao Wang, Weifen Li, Yun Xiang, Houhui Song, Dong Niu
Coronaviruses have been identified as pathogens of gastrointestinal and respiratory diseases in humans and various animal species. In recent years, the global spread of new coronaviruses has had profound influences for global public health and economies worldwide. As highly pathogenic zoonotic viruses, coronaviruses have become the focus of current research. Porcine Deltacoronavirus (PDCoV), an enterovirus belonging to the family of coronaviruses, has emerged on a global scale in the past decade and significantly influenced the swine industry...
April 24, 2024: Functional & Integrative Genomics
https://read.qxmd.com/read/38649535/assessment-of-tunable-resistive-pulse-sensing-trps-technology-for-particle-size-distribution-in-vaccine-formulations-a-comparative-study-with-dynamic-light-scattering
#44
JOURNAL ARTICLE
Rahul Misra, Ginny Fung, Siddhant Sharma, Jian Hu, Marina Kirkitadze
PURPOSE: A comparative assessment was performed to evaluate the potential of particle sizing by an ensemble based conventional dynamic light scattering (DLS) technique and an emerging technology based on tunable resistive pulse sensing (TRPS) using particle by particle approach by evaluating three different types of vaccine formulations representing three case studies and showing the limitation of each technique, instrument variability, sensitivity, and the resolution in mixed population...
April 22, 2024: Pharmaceutical Research
https://read.qxmd.com/read/38646911/invasive-pneumococcal-diseases-in-chinese-children-a-multicenter-hospital-based-active-surveillance-from-2019-2021
#45
JOURNAL ARTICLE
Xue Ning, Lianmei Li, Jing Liu, Fang Wang, Kun Tan, Wenhui Li, Kai Zhou, Shujun Jing, Aiwei Lin, Jing Bi, Shiyong Zhao, Huiling Deng, Chunhui Zhu, Shanshan Lv, Juan Li, Jun Liang, Qing Zhao, Yumin Wang, Biquan Chen, Liang Zhu, Guowu Shen, Jianlong Liu, Zhi Li, Jikui Deng, Xin Zhao, Mingfeng Shan, Yi Wang, Shihua Liu, Tingting Jiang, Xuexia Chen, Yufeng Zhang, Sha Cai, Lixue Wang, Xudong Lu, Jinghui Jiang, Fang Dong, Lan Ye, Jing Sun, Kaihu Yao, Yonghong Yang, Gang Liu
This study aimed to provide data for the clinical features of invasive pneumococcal disease (IPD) and the molecular characteristics of Streptococcus pneumoniae isolates from pediatric patients in China. We conducted a multi-center prospective study for IPD in 19 hospitals across China from January 2019 to December 2021. Data of demographic characteristics, risk factors for IPD, death, and disability was collected and analyzed. Serotypes, antibiotic susceptibility, and multi-locus sequence typing (MLST) of pneumococcal isolates were also detected...
April 22, 2024: Emerging Microbes & Infections
https://read.qxmd.com/read/38646136/cervical-precancerous-and-cancerous-lesions-screening-using-pap-smear-test-at-provincial-referral-hospital-of-bukavu-eastern-dr-congo-profile-and-recommendations-to-stakeholders
#46
JOURNAL ARTICLE
Daniel Garhalangwanamuntu Mayeri, Pierre Mulumeoderhwa Kahasha, Isaac Barhishindi Kibalama, Jules Mongane, Medina Louguè, Etienne Kajibwami Birindwa, Serge Chentwali Mwimangire, Claude Kalegamire Kikuru, Jeanne Maningo Materanya, Yvette Kujirakwinja Bisimwa, Benjamin Kasago, Léon-Emmanuel Mubenga Mukengeshai
INTRODUCTION: cervical cancer is a health concern worldwide. The South Kivu Province in the Eastern DR Congo is facing many cases of this disease but poorly screened and reported. The objective of this was to determine the prevalence of cell abnormalities at cervical cytology in a tertiary teaching hospital in Bukavu and their association with common risk factors of cervical cancer. METHODS: a cross-sectional study was conducted on 142 women attending the Provincial Referral Hospital of Bukavu (HPGRB) from February to December 2021...
2024: Pan African Medical Journal
https://read.qxmd.com/read/38645870/-immunoadjuvant-effect-of-chitosan-oligosaccharide-and-its-feasibility-of-being-used-as-an-adjuvant-for-attenuated-live-bacteria-vector-vaccines
#47
JOURNAL ARTICLE
Qian Ou, Zhaobin Chen, Jing Tang, Mengdie Chen, Yunwen Zhang, Zinan Chen, Qu Liu, Junrong Luo, Chuan Wang
OBJECTIVE: To study the immunoadjuvant effects of chitosan oligosaccharide (COS), including the immune activation and the triggering of lysosomal escape, and to explore whether COS can be used as an adjuvant for attenuated live bacteria vector vaccines. METHODS: 1) Mouse macrophages RAW264.7 cells were cultured with COS at 0 mg/mL (the control group) and 0.1-4 mg/mL for 24 h and the effect on cell viability was measured by CCK8 assay. Mouse macrophages RAW264.7 were treated with COS at 0 (the control group), 1, 2, and 4 mg/mL for 24 h...
March 20, 2024: Sichuan da Xue Xue Bao. Yi Xue Ban, Journal of Sichuan University. Medical Science Edition
https://read.qxmd.com/read/38644633/knowledge-about-attitudes-toward-and-acceptance-and-predictors-of-intention-to-receive-the-mpox-vaccine-among-cancer-patients-in-china-a-cross-sectional-survey
#48
JOURNAL ARTICLE
Jie Ding, Xing-Chen Liu, Jing Hong, Qing-Mei Zhang, Xiao-Wan Xu, Yi-Qun Liu, Chao-Qin Yu
This study aimed to investigate the knowledge about, attitudes toward, and acceptance and predictors of receiving the mpox vaccine among Chinese cancer patients. Patients were selected using a convenience sampling method. A web-based self-report questionnaire was developed to assess cancer patients' knowledge, attitudes, and acceptance regarding the mpox vaccine. Multivariate logistic regression analysis was used to determine predictors of acceptance of the mpox vaccine. A total of 805 cancer patients were included in this study, with a vaccine hesitancy rate of 27...
December 31, 2024: Human Vaccines & Immunotherapeutics
https://read.qxmd.com/read/38641954/the-role-and-impact-of-viruses-on-cancer-development
#49
REVIEW
Adolfo Contreras, Sandra Amaya Sánchez, Carolina Rodríguez-Medina, Javier Enrique Botero
This review focuses on three major aspects of oncoviruses' role in cancer development. To begin, we discuss their geographic distribution, revealing that seven oncoviruses cause 20% of all human cancers worldwide. Second, we investigate the primary carcinogenic mechanisms, looking at how these oncogenic viruses can induce cellular transformation, angiogenesis, and local and systemic inflammation. Finally, we investigate the possibility of SARS-CoV-2 infection reactivating latent oncoviruses, which could increase the risk of further disease...
April 20, 2024: Periodontology 2000
https://read.qxmd.com/read/38641595/design-of-a-multi-epitope-based-vaccine-candidate-against-bovine-genital-campylobacteriosis-using-a-reverse-vaccinology-approach
#50
JOURNAL ARTICLE
Marta Filipa Silva, Gonçalo Pereira, Luísa Mateus, Luís Lopes da Costa, Elisabete Silva
BACKGROUND: Bovine Genital Campylobacteriosis (BGC), a worldwide distributed venereal disease caused by Campylobacter fetus subsp. venerealis (Cfv), has a relevant negative economic impact in cattle herds. The control of BGC is hampered by the inexistence of globally available effective vaccines. The present in silico study aimed to develop a multi-epitope vaccine candidate against Cfv through reverse vaccinology. RESULTS: The analysis of Cfv strain NCTC 10354 proteome allowed the identification of 9 proteins suitable for vaccine development...
April 19, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38640729/preparation-and-brain-targeting-effects-study-of-recombinant-human-ferritin-nanoparticles
#51
JOURNAL ARTICLE
Zhixian Wang, Xiaoling Xu, Yunhuan Zhu, Yuncheng Qian, Yilu Feng, Hongyu Li, Guoheng Hu
Human heavy-chain ferritin is a naturally occurring protein with high stability and multifunctionality in biological systems. This study aims to utilize a prokaryotic expression system to produce recombinant human heavy-chain ferritin nanoparticles and investigate their targeting ability in brain tissue. The human heavy-chain ferritin gene was cloned into the prokaryotic expression vector pET28a and transformed into Escherichia coli BL21 (DE3) competent cells to explore optimal expression conditions. The recombinant protein was then purified to evaluate its immunoreactivity and characteristics...
April 15, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38640230/genomic-interactions-between-mycobacterium-tuberculosis-and-humans
#52
REVIEW
Prasit Palittapongarnpim, Pornpen Tantivitayakul, Pakorn Aiewsakun, Surakameth Mahasirimongkol, Bharkbhoom Jaemsai
Mycobacterium tuberculosis is considered by many to be the deadliest microbe, with the estimated annual cases numbering more than 10 million. The bacteria, including Mycobacterium africanum , are classified into nine major lineages and hundreds of sublineages, each with different geographical distributions and levels of virulence. The phylogeographic patterns can be a result of recent and early human migrations as well as coevolution between the bacteria and various human populations, which may explain why many studies on human genetic factors contributing to tuberculosis have not been replicable in different areas...
April 19, 2024: Annual Review of Genomics and Human Genetics
https://read.qxmd.com/read/38639919/integrating-multisector-molecular-characterization-into-personalized-peptide-vaccine-design-for-patients-with-newly-diagnosed-glioblastoma
#53
JOURNAL ARTICLE
Tanner M Johanns, Elizabeth A R Garfinkle, Katherine E Miller, Alexandra J Livingstone, Kaleigh F Roberts, Lakshmi Prakruthi Rao Venkata, Joshua L Dowling, Michael R Chicoine, Ralph G Dacey, Gregory J Zipfel, Albert H Kim, Elaine R Mardis, Gavin P Dunn
PURPOSE: Glioblastoma (GBM) patient outcomes remain poor despite multimodality treatment with surgery, radiation, and chemotherapy. There are few immunotherapy options due to the lack of tumor immunogenicity. Several clinical trials have reported promising results with cancer vaccines. To date, studies have used data from a single tumor site to identify targetable antigens, but this approach limits the antigen pool and is antithetical to the heterogeneity of GBM. We have implemented multisector sequencing to increase the pool of neoantigens across the GBM genomic landscape that can be incorporated into personalized peptide vaccines called NeoVax...
April 19, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38638823/second-booster-dose-improves-antibody-neutralization-against-ba-1-ba-5-and-bq-1-1-in-individuals-previously-immunized-with-coronavac-plus-bnt162b2-booster-protocol
#54
JOURNAL ARTICLE
Guilherme R F Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Jéssica Vieira de Assis, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Jaquelline Germano de Oliveira, Paula Rahal, Rafaella Fortini Queiroz Grenfell, Maurício L Nogueira
INTRODUCTION: SARS-CoV-2 vaccines production and distribution enabled the return to normalcy worldwide, but it was not fast enough to avoid the emergence of variants capable of evading immune response induced by prior infections and vaccination. This study evaluated, against Omicron sublineages BA.1, BA.5 and BQ.1.1, the antibody response of a cohort vaccinated with a two doses CoronaVac protocol and followed by two heterologous booster doses. METHODS: To assess vaccination effectiveness, serum samples were collected from 160 individuals, in 3 different time points (9, 12 and 18 months after CoronaVac protocol)...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38638589/spatial-distribution-of-zero-dose-children-in-ethiopia-evidence-for-a-targeted-intervention-from-a-large-scale-cross-sectional-evaluation-survey
#55
JOURNAL ARTICLE
Fisseha Shiferie, Samson Gebremedhin, Gashaw Andargie, Frank DelPizzo, Kidist Belete, Teferi Gedif Fenta
BACKGROUND: Ethiopia is the fourth leading contributor to the global total of zero-dose children (those who lack the first dose of diphtheria-tetanus-pertussis containing vaccine) and has substantial regional variations in zero-dose children. This study explored the spatial pattern of zero-dose children aged 12-35 months in Ethiopia. METHODS: A survey was conducted in pastoralist regions, developing regions, newly-established regions, conflict-affected areas, underserved urban populations, hard-to-reach areas, internally displaced populations, and refugees...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38637212/impact-of-nutritional-status-on-vaccine-induced-immunity-in-children-living-in-south-africa-investigating-the-b-cell-repertoire-and-metabolic-hormones
#56
JOURNAL ARTICLE
E A M L Mutsaerts, B van Cranenbroek, S A Madhi, E Simonetti, A J Arns, L Jose, A Koen, A E van Herwaarden, M I de Jonge, L M Verhagen
OBJECTIVES: We explored the role of metabolic hormones and the B-cell repertoire in the association between nutritional status and vaccine responses. METHODS: In this prospective cohort study, nested within a larger randomized open-label trial, 211 South African children received two doses of measles vaccine and two or three doses of pneumococcal conjugate vaccine (PCV). Metabolic markers (leptin, ghrelin and adiponectin) and distribution of B-cell subsets (n = 106) were assessed at 18 months of age...
April 17, 2024: Vaccine
https://read.qxmd.com/read/38635617/evaluation-of-covid-19-preventive-practices-among-sellers-in-the-beni-mellal-region-of-morocco
#57
JOURNAL ARTICLE
Abouddihaj Barguigua, Ilham Zahir
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus. It has impacted millions of individuals and caused numerous casualties. Consequently, there was a race to develop vaccines against the virus. However, there has been unequal vaccine distribution among nations, and concerns over side effects have resulted in vaccine hesitancy, reducing vaccination rates in many countries and hindering pandemic eradication. Preventive measures like well-fitted masks, frequent hand washing, alcohol-based sanitizers, and maintaining physical distance remain crucial to curb SARS-CoV-2 transmission...
March 31, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38633800/inapparent-primary-dengue-virus-infections-reveal-hidden-serotype-specific-epidemiological-patterns-and-spectrum-of-infection-outcome-a-cohort-study-in-nicaragua
#58
Sandra Bos, Jose Victor Zambrana, Elias Duarte, Aaron L Graber, Julia Huffaker, Carlos Montenegro, Lakshmanane Premkumar, Aubree Gordon, Angel Balmaseda, Eva Harris
BACKGROUND: Dengue is the most prevalent mosquito-borne viral disease and a major public health problem worldwide. Most primary infections with the four dengue virus serotypes (DENV1-4) are inapparent; nevertheless, prior research has primarily focused on symptomatic infections, which has limited our understanding of the epidemiological burden and spectrum of disease of each DENV serotype. Our study addresses this bottleneck in dengue research by providing a new method and a detailed examination of primary inapparent infections...
April 8, 2024: medRxiv
https://read.qxmd.com/read/38633263/boosting-the-immunogenicity-of-the-coronavac-sars-cov-2-inactivated-vaccine-with-huoxiang-suling-shuanghua-decoction-a-randomized-double-blind-placebo-controlled-study
#59
RANDOMIZED CONTROLLED TRIAL
Ruying Tang, Linyuan Wang, Jianjun Zhang, Wenting Fei, Rui Zhang, Jinlian Liu, Meiyu Lv, Mengyao Wang, Ruilin Lv, Haipeng Nan, Ran Tao, Yawen Chen, Yan Chen, Yanxin Jiang, Hui Zhang
INTRODUCTION: In light of the public health burden of the COVID-19 pandemic, boosting the safety and immunogenicity of COVID-19 vaccines is of great concern. Numerous Traditional Chinese medicine (TCM) preparations have shown to beneficially modulate immunity. Based on pilot experiments in mice that showed that supplementation with Huoxiang Suling Shuanghua Decoction (HSSD) significantly enhances serum anti-RBD IgG titers after inoculation with recombinant SARS-CoV-2 S-RBD protein, we conducted this randomized, double-blind, placebo-controlled clinical trial aimed to evaluate the potential immunogenicity boosting effect of oral HSSD after a third homologous immunization with Sinovac's CoronaVac SARS-CoV-2 (CVS) inactivated vaccine...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38627989/new-onset-of-rheumatic-diseases-following-covid-19-vaccination-the-report-of-three-cases-and-a-literature-review
#60
JOURNAL ARTICLE
Mayumi Matsuda, Yu Funakubo Asanuma, Kyohei Emoto, Sakon Sakai, Nobuhito Okumura, Hiroaki Yazawa, Takashi Maruyama, Takuma Tsuzuki Wada, Kazuhiro Yokota, Yasuto Araki, Yuji Akiyama, Toshihide Mimura
Vaccines against coronavirus disease 2019 (COVID-19) have been distributed in most countries for the prevention of onset and aggravation of COVID-19. Recently, there have been increasing numbers of reports on new-onset autoimmune and autoinflammatory diseases following COVID-19 vaccination, however, only little information is available on the long-term safety of these vaccines. Here, we experienced three cases of new-onset rheumatic diseases following COVID-19 vaccination, one case each of rheumatoid arthritis (RA), anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and systemic lupus erythematosus (SLE)...
April 16, 2024: Immunological Medicine
keyword
keyword
35725
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.